(-0.07%) 5 043.75 points
(-0.03%) 38 455 points
(-0.14%) 17 326 points
(0.21%) $83.02
(-0.28%) $1.786
(-1.27%) $2 316.60
(-1.36%) $26.88
(-1.32%) $919.00
(0.11%) $0.939
(0.16%) $11.00
(0.05%) $0.810
(-0.09%) $93.33
Live Chart Being Loaded With Signals
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names...
Stats | |
---|---|
Today's Volume | 450.00 |
Average Volume | 3.85M |
Market Cap | 3.69B |
EPS | £0 ( 2023-11-14 ) |
Last Dividend | £3.00 ( 2022-08-04 ) |
Next Dividend | £0 ( N/A ) |
P/E | 21.78 |
ATR14 | £1.585 (0.32%) |
Volume Correlation
Mediclinic International Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Mediclinic International Correlation - Currency/Commodity
Mediclinic International Financials
Annual | 2022 |
Revenue: | £3.23B |
Gross Profit: | £505.00M (15.62 %) |
EPS: | £0.210 |
Q2 | 2021 |
Revenue: | £770.75M |
Gross Profit: | £280.75M (36.43 %) |
EPS: | £-0.109 |
Q1 | 2021 |
Revenue: | £770.75M |
Gross Profit: | £280.75M (36.43 %) |
EPS: | £-0.109 |
Q4 | 2020 |
Revenue: | £770.75M |
Gross Profit: | £280.75M (36.43 %) |
EPS: | £-0.109 |
Financial Reports:
No articles found.
Mediclinic International Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£3.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £5.24 | 2016-06-16 |
Last Dividend | £3.00 | 2022-08-04 |
Next Dividend | £0 | N/A |
Payout Date | 2022-08-26 | |
Next Payout Date | N/A | |
# dividends | 9 | -- |
Total Paid Out | £35.14 | -- |
Avg. Dividend % Per Year | 0.19% | -- |
Score | 2.59 | -- |
Div. Sustainability Score | 8.34 | |
Div.Growth Potential Score | 4.50 | |
Div. Directional Score | 6.42 | -- |
Year | Amount | Yield |
---|---|---|
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £7.90 | 1.17% |
2019 | £7.90 | 2.50% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £3.00 | 0.94% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SVS.L | Dividend Knight | 2023-08-31 | Annually | 32 | 1.81% | |
KYGA.L | Dividend Knight | 2023-10-12 | Semi-Annually | 25 | 0.55% | |
CHH.L | Dividend Knight | 2023-09-21 | Annually | 30 | 1.09% | |
RBGP.L | Dividend Junior | 2023-05-04 | Semi-Annually | 6 | 2.45% | |
GRI.L | Dividend Knight | 2023-05-25 | Semi-Annually | 32 | 1.04% | |
ARTL.L | Dividend Knight | 2023-09-28 | Quarterly | 12 | 1.39% | |
TPT.L | Dividend Knight | 2023-06-08 | Annually | 27 | 2.93% | |
MERC.L | Ex Dividend Junior | 2023-09-28 | Annually | 5 | 0.78% | |
CTO.L | Dividend King | 2023-08-31 | Semi-Annually | 32 | 2.55% | |
RWS.L | Dividend Knight | 2023-06-22 | Semi-Annually | 21 | 1.50% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0467 | 1.500 | 9.07 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0210 | 1.200 | 9.30 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0507 | 1.500 | -0.548 | -0.822 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.791 | 0.800 | 6.04 | 4.84 | [1 - 3] |
quickRatioTTM | 0.656 | 0.800 | -0.846 | -0.677 | [0.8 - 2.5] |
cashRatioTTM | 0.649 | 1.500 | 7.51 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.359 | -1.500 | 4.01 | -6.02 | [0 - 0.6] |
interestCoverageTTM | 4.52 | 1.000 | 9.44 | 9.44 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.751 | 2.00 | 9.75 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.509 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.833 | -1.500 | 6.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.156 | 1.000 | -0.730 | -0.730 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0866 | 1.000 | -0.268 | -0.268 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.214 | 1.000 | 9.92 | 9.92 | [0.2 - 2] |
assetTurnoverTTM | 0.449 | 0.800 | -0.343 | -0.274 | [0.5 - 2] |
Total Score | 8.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.46 | 1.000 | 7.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0507 | 2.50 | -0.352 | -0.822 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.509 | 2.00 | 9.83 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.751 | 2.00 | 9.75 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 19.07 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.171 | 1.000 | 8.22 | 0 | [0.1 - 0.5] |
Total Score | 4.50 |
Mediclinic International
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators